TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33420829

Group type: EXPERIMENTAL
Intervention: Intraoral cooling device (ICD) set to 8 °C
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intraoral cooling device (ICD) set to 15 °C
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intraoral cooling device (ICD)
Number of subjects: 20
Study: 32149617

Group type: COMPARATOR
Intervention: FMS patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: CFS patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched healthy individuals
Number of subjects: 0
Study: 35763658

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg
Number of subjects: 140
Study: 33744810

Group type: EXPERIMENTAL
Intervention: Training Program MOTIVA (16 hours initial course + online activities for 12 months + Problem Based Interviewing with expert feedback)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control Group (no training)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Training Program MOTIVA (12 months follow-up)
Number of subjects: 54
Study: 36181304

Group type: COMPARATOR
Intervention: 0.5 mg/day placebo
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 0.5 mg/day melatonin
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: 0.5 mg/day melatonin plus 30 min of bright light therapy (BLT)
Number of subjects: 49
Study: 33539612

Group type: EXPERIMENTAL
Intervention: Lateral or mediolateral episiotomy
Number of subjects: 63654

Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 63654
Study: 33339415

Group type: EXPERIMENTAL
Intervention: Integrated nutrition behavior change interventions
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 340
Study: 35580595

Group type: EXPERIMENTAL
Intervention: Two-handed mask holding
Number of subjects: 80

Group type: COMPARATOR
Intervention: One-handed mask holding
Number of subjects: 80
Study: 34301645

Group type: EXPERIMENTAL
Intervention: Presence of older children in the home
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Cooking outside the home
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Weighted incidence of childhood injury
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Common mechanisms of injury
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Age group differences in mechanism of injury
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Gender differences in injury incidence
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Common modifiable risk factors (stove height, fuel type, secured cabinets)
Number of subjects: 357
Study: 35700691

Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg under fasting conditions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Bilastine 20 mg under fed conditions
Number of subjects: 24
Study: 33189179

Group type: EXPERIMENTAL
Intervention: Progestogen-only pill (75 μg desogestrel) plus a rapid access card to a sexual and reproductive health clinic
Number of subjects: 636

Group type: COMPARATOR
Intervention: Control group advised to attend their usual contraceptive provider
Number of subjects: 636
Study: 35661487

Group type: EXPERIMENTAL
Intervention: Four-food elimination diet (FFED)
Number of subjects: 40
Study: 32975923

Group type: EXPERIMENTAL
Intervention: Neurofascial dextrose prolotherapy (8 mL of 12.5% dextrose and 40 mg of 2% lidocaine, injected 2 times with 1-week interval)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Neurofascial dextrose prolotherapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Physiotherapy (superficial heat, transcutaneous electrical nerve stimulation, pulsed ultrasound, and exercise program, 10 sessions of 30 minutes for 3 weeks)
Number of subjects: 66
Study: 33059233

Group type: EXPERIMENTAL
Intervention: Ultrasound biofeedback during contractions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard contractions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Golf-setup position
Number of subjects: 32

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 32
Study: 35571644

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 80

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 80
Study: 34939872

Group type: EXPERIMENTAL
Intervention: Training in coping skills and coping with stress self-efficacy (15 sessions, twice per week for 8 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pharmacological therapy (control group)
Number of subjects: 14
Study: 35696234

Group type: EXPERIMENTAL
Intervention: Ball attachment (Group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Locator attachment (Group B)
Number of subjects: 80
Study: 32949140

Group type: EXPERIMENTAL
Intervention: Seletalisib 45 mg/day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 33412997

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) started from 40% of MIP, given in addition to a neurodevelopmental treatment program for 5 days a week for 6 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no IMT), received the same neurodevelopmental treatment program
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 21
Study: 33710385

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: COPD status
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: CABG vs PCI in COPD patients
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: CABG vs PCI in non-COPD patients
Number of subjects: 1800

Group type: EXPERIMENTAL
Intervention: Treatment effect of CABG vs PCI
Number of subjects: 1800
Study: 32286711

Group type: EXPERIMENTAL
Intervention: Continuous Aerobic Training (CAT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intermittent Aerobic Training (IAT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 87
Study: 35291433

Group type: EXPERIMENTAL
Intervention: Melatonin (10 mg)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 32081236

Group type: EXPERIMENTAL
Intervention: DCB angioplasty
Number of subjects: 358

Group type: COMPARATOR
Intervention: PTA
Number of subjects: 358
Study: 35729759

Group type: EXPERIMENTAL
Intervention: Modafinil (200 mg oral dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34158376

Group type: EXPERIMENTAL
Intervention: Serratus block (ropivacaine 0.5%; 20 mL unilateral; 16 mL/side bilateral)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paravertebral block (ropivacaine 0.5%; 20 mL unilateral; 16 mL/side bilateral)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Serratus block
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paravertebral block
Number of subjects: 100
Study: 32183769

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) with a comprehensive pre-treatment assessment interview
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) with guidance from a health educator
Number of subjects: 300

Group type: COMPARATOR
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) without pre-treatment assessment interview
Number of subjects: 300

Group type: COMPARATOR
Intervention: Internet-delivered cognitive behaviour therapy (ICBT) without guidance from a health educator
Number of subjects: 300
Study: 35729492

Group type: EXPERIMENTAL
Intervention: Multiple Single Cannulation Technique (MuST)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Rope-ladder (RL) technique
Number of subjects: 200
Study: 32448056

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (8-minute audio recording)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Audiobook listening (control group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passing the time (control group)
Number of subjects: 0
Study: 35049252

Group type: EXPERIMENTAL
Intervention: Caries group (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy group (n = 25)
Number of subjects: 50
Study: 33636418

Group type: EXPERIMENTAL
Intervention: 3 g of fish oil ω‐3 fatty acids daily
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 3 g of fish oil n‐3 fatty acids and 500 mL of reduced‐calorie cranberry juice daily
Number of subjects: 62

Group type: COMPARATOR
Intervention: Typical diet (Control)
Number of subjects: 62
Study: 34480075

Group type: EXPERIMENTAL
Intervention: trichlormethiazide
Number of subjects: 10
Study: 35998767

Group type: EXPERIMENTAL
Intervention: Enhanced online training incorporating additional modules related to externalization and agnosticism
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard webinar-based online training
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Both training arms (Enhanced and Standard)
Number of subjects: 140
Study: 34639600

Group type: EXPERIMENTAL
Intervention: FIBROWALK plus Treatment-As-Usual (TAU)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Treatment-As-Usual (TAU)
Number of subjects: 151
Study: 32323706

Group type: EXPERIMENTAL
Intervention: Probiotics administration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 40
Study: 36431093

Group type: EXPERIMENTAL
Intervention: Real dry needling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 60
Study: 33033863

Group type: EXPERIMENTAL
Intervention: Radiomics model using CT images
Number of subjects: 203

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Combined logistic model
Number of subjects: 203
Study: 35779938

Group type: EXPERIMENTAL
Intervention: Was It Worth It? (WIWI) questionnaire item 1
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Was It Worth It? (WIWI) questionnaire item 2
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Was It Worth It? (WIWI) questionnaire item 3
Number of subjects: 65

Group type: COMPARATOR
Intervention: Patients responding yes to item 1 vs uncertain/no
Number of subjects: 65
Study: 33914661

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate/formoterol fumarate (GFF)
Number of subjects: 48
Study: 33736696

Group type: EXPERIMENTAL
Intervention: Early ART initiation (within 2 weeks after anti-CMV therapy)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Deferred ART initiation (more than 2 weeks after anti-CMV therapy)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Early ART initiation
Number of subjects: 300

Group type: COMPARATOR
Intervention: Deferred ART initiation
Number of subjects: 300
Study: 35320643

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (4 mg per kilogram of body weight per day tapered over a period of 10 days)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 800
Study: 34787240

Group type: EXPERIMENTAL
Intervention: Adjuvant low‐laser light therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment alone (topical and compressive treatment)
Number of subjects: 40
Study: 32867985

Group type: EXPERIMENTAL
Intervention: Turning frequency of 12 times per day
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Turning frequency of 6 times per day
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Turning frequency of 3 times per day
Number of subjects: 960

Group type: COMPARATOR
Intervention: Turning frequency of 24 times per day
Number of subjects: 960
Study: 34981862

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 32015127

Group type: EXPERIMENTAL
Intervention: Parent coaching intervention
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 71
Study: 36129087

Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Erector spine plane block (ESPB)
Number of subjects: 60
Study: 33203537

Group type: EXPERIMENTAL
Intervention: Elastic band resistance training for 14 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (passive during intervention)
Number of subjects: 42
Study: 33111950

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multilevel single-shot thoracic paravertebral blockade (PVB) from T2 to T5
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided multilevel single-shot thoracic paravertebral blockade (PVB)
Number of subjects: 218
Study: 35904473

Group type: EXPERIMENTAL
Intervention: Humid conditions (n=833)
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Humid conditions with PGT-A
Number of subjects: 1627

Group type: COMPARATOR
Intervention: Dry conditions (n=794)
Number of subjects: 1627
Study: 33236860

Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (INPWT) applied after primary closure of the midline sternotomy (n = 52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional wound dressing applied in the control group (n = 52)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Incisional negative pressure wound therapy (INPWT)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional wound dressing
Number of subjects: 104
Study: 33782092

Group type: EXPERIMENTAL
Intervention: Medication adherence management intervention
Number of subjects: 1186

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1186
Study: 33901231

Group type: EXPERIMENTAL
Intervention: Family annual cash income less than 24000ETB
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: History of still birth
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: History of abortion
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Preconception tea use
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Pesticides/chemical exposure
Number of subjects: 243

Group type: COMPARATOR
Intervention: Preconception care
Number of subjects: 243

Group type: COMPARATOR
Intervention: Taking iron/folic acid/multivitamin during the current pregnancy
Number of subjects: 243
Study: 34924513

Group type: EXPERIMENTAL
Intervention: Antigravity treadmill therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 32198963

Group type: EXPERIMENTAL
Intervention: TAP catheter group (TAP-C) infused with 0.2% ropivacaine at 10 mL/h
Number of subjects: 70

Group type: COMPARATOR
Intervention: TAP saline group (TAP-S) infused with saline at 10 mL/h
Number of subjects: 70
Study: 36174261

Group type: EXPERIMENTAL
Intervention: Correction condition
Number of subjects: 612

Group type: COMPARATOR
Intervention: Test-retest control
Number of subjects: 612
Study: 34271265

Group type: EXPERIMENTAL
Intervention: HOM-HEMP intervention (experimental groups A and B)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: HOM-HEMP intervention (experimental group B)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study: 32100499

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture for 30 min, 5 min before routine local infiltration anesthesia.
Number of subjects: 64

Group type: COMPARATOR
Intervention: 1% lidocaine for routine local infiltration anesthesia.
Number of subjects: 64
Study: 35914911

Group type: EXPERIMENTAL
Intervention: S-ketamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 0
Study: 33535690

Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal stimulation at 2 mA for 20 min over F7)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 29
Study: 32747302

Group type: EXPERIMENTAL
Intervention: Fluoropyrimidine plus bevacizumab as maintenance treatment
Number of subjects: 400

Group type: COMPARATOR
Intervention: Fluoropyrimidine alone as maintenance treatment
Number of subjects: 400
Study: 35395943

Group type: EXPERIMENTAL
Intervention: Auxora
Number of subjects: 261

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 261
Study: 33449848

Group type: EXPERIMENTAL
Intervention: Inorganic nitrate supplementation (4.03 mmol nitrate and 0.29 mmol nitrite daily for 4 weeks)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (devoid of nitrate and nitrite)
Number of subjects: 10
Study: 33102416

Group type: EXPERIMENTAL
Intervention: Techno-social innovations aimed at improving father's involvement in child-care
Number of subjects: 0
Study: 34453996

Group type: EXPERIMENTAL
Intervention: Nutri-score
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light (MTL) label
Number of subjects: 300

Group type: COMPARATOR
Intervention: No label control condition
Number of subjects: 300
Study: 34689055

Group type: EXPERIMENTAL
Intervention: Trauma-NF
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Neutral-NF
Number of subjects: 59

Group type: COMPARATOR
Intervention: No-NF
Number of subjects: 59
Study: 35560262

Group type: EXPERIMENTAL
Intervention: Financial assistance to attend the cancer screening programme
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control group (no financial assistance)
Number of subjects: 412
Study: 32887850

Group type: EXPERIMENTAL
Intervention: Self-efficacy intervention (six weekly individual physical therapy sessions for lower-extremity exercise and fitness walking; nine biweekly nurse telephone counseling sessions)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Attention-control intervention (six weekly and nine biweekly nurse telephone sessions on health topics)
Number of subjects: 182
Study: 34245081

Group type: EXPERIMENTAL
Intervention: HepB-alum vaccine
Number of subjects: 8138

Group type: COMPARATOR
Intervention: Control group (no HepB-alum vaccine)
Number of subjects: 8138

Group type: EXPERIMENTAL
Intervention: HepB-alum vaccination
Number of subjects: 8138
Study: 32112114

Group type: EXPERIMENTAL
Intervention: remifentanil (3 μg/kg) + propofol (2.5 mg/kg)
Number of subjects: 70

Group type: COMPARATOR
Intervention: sufentanil (0.3 μg/kg) + propofol (2.5 mg/kg)
Number of subjects: 70
Study: 36214061

Group type: EXPERIMENTAL
Intervention: 2% minoxidil combined with microneedling (weekly)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2% minoxidil (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined treatment group (microneedling + minoxidil)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 34482089

Group type: EXPERIMENTAL
Intervention: CAC-disclosed group (atorvastatin treatment)
Number of subjects: 450

Group type: COMPARATOR
Intervention: CAC-blinded group (risk factor education only)
Number of subjects: 450
Study: 33569725

Group type: EXPERIMENTAL
Intervention: Surveillance colonoscopy at 3, 6, 12, and 24 months after p-EMR (group A; n = 90)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Surveillance colonoscopy at 6, 12, and 24 months after p-EMR (group B; n = 90)
Number of subjects: 180
Study: 33609618

Group type: EXPERIMENTAL
Intervention: Structured clinical algorithm for scheduled counselling, glucose monitoring, and adjustment of medication
Number of subjects: 150

Group type: COMPARATOR
Intervention: Routine diabetes management (control)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Structured clinical algorithm
Number of subjects: 150
Study: 32360129

Group type: EXPERIMENTAL
Intervention: Active warming method
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine care via a cotton blanket
Number of subjects: 64
Study: 35302688

Group type: EXPERIMENTAL
Intervention: N-acetyl aspartyl glutamic acid (4.9%, NAAGA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fluorometholone (0.1%, FM)
Number of subjects: 24
Study: 33176772

Group type: EXPERIMENTAL
Intervention: Oral health assessment using WHO Oral Health Assessment form 1997 and WHO oral health assessment questionnaire for adult/children 2013
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Assessment of treatment needs
Number of subjects: 310
Study: 33902550

Group type: EXPERIMENTAL
Intervention: Propylene mesh
Number of subjects: 24

Group type: COMPARATOR
Intervention: Custom-made acrylic stent
Number of subjects: 24
Study: 34090775

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU/d)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Fruit juice without vitamin D (Control)
Number of subjects: 26
Study: 32205704

Group type: COMPARATOR
Intervention: BrAIST (TLSO)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: ISICO (SPoRT braces with or without SEAS exercises)
Number of subjects: 238
Study: 36449318

Group type: EXPERIMENTAL
Intervention: 2.5-day training on managing common child mental health problems
Number of subjects: 389

Group type: COMPARATOR
Intervention: Refresher training on identification and referral
Number of subjects: 389
Study: 32918607

Group type: EXPERIMENTAL
Intervention: Mobile-assisted empowerment program
Number of subjects: 74
Study: 32711393

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Concurrent training with resistive equipment (CTRE)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Concurrent training with multiple sets (CTMS)
Number of subjects: 57
Study: 35131037

Group type: EXPERIMENTAL
Intervention: Semaglutide 2·4 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Semaglutide 1·7 mg
Number of subjects: 401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study: 33371109

Group type: EXPERIMENTAL
Intervention: Web-based intervention (WBI)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study: 34099328

Group type: EXPERIMENTAL
Intervention: IHV01 vaccine (75 µg, 150 µg, and 300 µg doses)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: IHV01 vaccine
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 65
Study: 32419935

Group type: EXPERIMENTAL
Intervention: Single dose of oral dexamethasone 0.3 mg/kg (maximum 12 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Oral dexamethasone 0.6 mg/kg/day for 2 days (maximum 16 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral prednisolone 1.5 mg/kg/day for 5 days (maximum 60 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 34156758

Group type: EXPERIMENTAL
Intervention: Spray-on skin (ReCell)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 45